|
mutLBSgeneDB |
| |
| |
| |
| |
| |
| |
|
| Gene summary for KIF15 |
Gene summary |
| Basic gene Info. | Gene symbol | KIF15 |
| Gene name | kinesin family member 15 | |
| Synonyms | HKLP2|KNSL7|NY-BR-62 | |
| Cytomap | UCSC genome browser: 3p21.31 | |
| Type of gene | protein-coding | |
| RefGenes | NM_020242.2, | |
| Description | kinesin-like 7kinesin-like protein 2kinesin-like protein 7kinesin-like protein KIF15serologically defined breast cancer antigen NY-BR-62 | |
| Modification date | 20141215 | |
| dbXrefs | HGNC : HGNC | |
| Ensembl : ENSG00000163808 | ||
| HPRD : 10037 | ||
| Vega : OTTHUMG00000156307 | ||
| Protein | UniProt: Q9NS87 go to UniProt's Cross Reference DB Table | |
| Expression | CleanEX: HS_KIF15 | |
| BioGPS: 56992 | ||
| Pathway | NCI Pathway Interaction Database: KIF15 | |
| KEGG: KIF15 | ||
| REACTOME: KIF15 | ||
| Pathway Commons: KIF15 | ||
| Context | iHOP: KIF15 | |
| ligand binding site mutation search in PubMed: KIF15 | ||
| UCL Cancer Institute: KIF15 | ||
| Assigned class in mutLBSgeneDB | C: This gene just belongs to mutLBSgenes. | |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
| GO ID | GO Term | PubMed ID |
| Top |
| Ligand binding site mutations for KIF15 |
Lollipop-style diagram of mutations at LBS in amino-acid sequence. We represented ligand binding site mutations only. (You can see big image via clicking.) |
![]() |
Cancer type specific mutLBS sorted by frequency |
| LBS | AAchange of nsSNV | Cancer type | # samples | R34 | R34C | STAD | 1 |
| cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
| Top |
| Protein structure related information for KIF15 |
Relative protein structure stability change (ΔΔE) using Mupro 1.1 Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
: nsSNV at non-LBS : nsSNV at LBS |
![]() |
nsSNVs sorted by the relative stability change of protein structure by each mutation Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
| LBS | AAchange of nsSNV | Relative stability change | R34 | R34C | -1.0780643 |
| (MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
Structure image for KIF15 from PDB |
| Top |
| Differential gene expression and gene-gene network for KIF15 |
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types |
Differential co-expressed gene network based on protein-protein interaction data (CePIN) |
| Top |
| Top |
| Phenotype information for KIF15 |
Gene level disease information (DisGeNet) |
| Disease ID | Disease name | # PubMed | Association type |
| umls:C0017661 | Glomerulonephritis, IGA | 1 | Biomarker |
Mutation level pathogenic information (ClinVar annotation) |
| Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
| Top |
| Pharmacological information for KIF15 |
Gene expression profile of anticancer drug treated cell-lines (CCLE)Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient. |
![]() |
Drug information targeting mutLBSgene (Approved drugs only) |
| Drug status | DrugBank ID | Name | Type | Drug structure |
Gene-centered ligand-gene interaction network |
![]() |
Ligands binding to mutated ligand binding site of KIF15 go to BioLip |
| Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS |
| Top |
| Conservation information for LBS of KIF15 |
Multiple alignments for Q9NS87 in multiple species |
| LBS | AA sequence | # species | Species | F117 | GSGKTFTMMGP | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | G112 | AYGQTGSGKTF | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | G114 | GQTGSGKTFTM | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | K115 | QTGSGKTFTMM | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | P35 | FVRIRPAEEGA | 2 | Mus musculus, Rattus norvegicus | P35 | FVRIRPPAERS | 1 | Homo sapiens | Q110 | IFAYGQTGSGK | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | R32 | IKVFVRIRPAE | 2 | Mus musculus, Rattus norvegicus | R32 | IKVFVRIRPPA | 1 | Homo sapiens | R34 | VFVRIRPAEEG | 2 | Mus musculus, Rattus norvegicus | R34 | VFVRIRPPAER | 1 | Homo sapiens | S113 | YGQTGSGKTFT | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | T111 | FAYGQTGSGKT | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | T116 | TGSGKTFTMMG | 3 | Homo sapiens, Mus musculus, Rattus norvegicus |
![]() |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |